Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults
Clinical trial NCT06815991 · RECRUITING
Trial details
- NCT number
- NCT06815991
- Sponsor
- Metro International Biotech, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-11
- Primary completion
- 2026-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.